Clinical Trials in Hezhou, Guangxi
4 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
HPV-Related CarcinomaHPV Infection
National Vaccine and Serum Institute, China13,500 enrolled8 locationsNCT05262010
Recruiting
Phase 3
Normobaric Oxygen in AIS Transferred for EVT
Ischemic Stroke
Capital Medical University1,500 enrolled112 locationsNCT06666764